LSMO-03 - From clinic to counter: Guiding better self-care pain management with multimodal analgesia (Supported by Haleon)

Last updated: June 26, 2026, 4:51 am

« Back to Agenda

LSMO-03 - From clinic to counter: Guiding better self-care pain management with multimodal analgesia (Supported by Haleon)

Tracks
Room 519
Monday, August 31, 2026
1:00 PM - 2:00 PM

Details

Lunch break symposium supported by Haleon Chair(s) To be announced Introduction: A scientific symposium exploring the role of a multimodal approach in the management of acute pain within self-care settings. The session will review the clinical evidence base, including relevant guidelines and published data, and discuss how different therapeutic strategies can support effective, and appropriate pain management Particular focus will be placed on the role of pharmacists in translating evidence into practice, supporting patient-centred decision making, considering individual patient factors, and ensuring the appropriate use of treatments in community settings. Programme:
13:00 – 13:05 Introduction by the chair
13:05 – 13:20 From Evidence to Practice: Support Pharmacist Decision-Making in Multimodal Pain Management
Prof. Zubin Austin, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
13:20 – 13:40 Bridging Care: Multimodal Analgesia Across the Age Continuum
Dr Ian M Paul, Department of Paediatrics and Public Health Sciences, Penn State College of Medicine. USA
13:40 – 13:55 Panel discussion with chairs, speakers and additional panellists and Q&A Session
Dr Pamela Kushner, Kushner Wellness Center, USA
14:10 – 14:15 Closing by the chairs
Learning objectives: 1. Apply multimodal analgesia in practice: Understand the clinical value of acetaminophen + NSAIDs (acetaminophen + ibuprofen) FDC as compared as to single-agent therapy, informed by published data and guideline recommendations. 2. Equip pharmacists with practical frameworks to guide optimized pain management choices across patient needs and life stages, supporting appropriate use of analgesic FDCs as effective opioid sparing options. 3. Support adherence and usability: Differentiate treatment approaches (e.g., fixed dose combinations versus alternating regimens) to improve clarity, adherence, and effectiveness in routine clinical practice. Take home messages: The unmet need in pain management within multimodal analgesia in self-care settings. Evidence supporting improved pain management outcomes with multimodal approaches versus monotherapy in the pharmacy setting. Analgesic strategy with acetaminophen–NSAIDs multimodal approach vs Weak Opioids. Pharmacists as key facilitators of patient centred pain management in guiding analgesic FDC selection and use.

loading